Signal active
Contact Information
Social
Primary Organization
1991
51-100
Biotechnology, Pharmaceutical, Biopharma
Bio
Sujal Shah is the President and Chief Executive Officer at CymaBay Therapeutics. Sujal Shah attended Carnegie Mellon University - Tepper School of Business.
Location
N/A
Jobs history
2
Member, Board Of Directors
2020 - Current
CymaBay Therapeutics
Founder, President and Chief Executive Officer
2017 - Current
Educations
1
N/A
Profile Resume
Sujal Shah is the Founder, President and Chief Executive Officer at CymaBay Therapeutics, based in United States, North America. With a background in Biotechnology, Sujal Shah has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.